These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
141 related items for PubMed ID: 88280
1. Adriamycin, bleomycin, vinblastine and imidazole carboxamide (ABVD) therapy for advanced Hodgkin's disease resistant to mustine, vinblastine, procarbazine and prednisolone (MVPP). Sutcliffe SB, Wrigley PF, Stansfeld AG, Malpas JS. Cancer Chemother Pharmacol; 1979; 2(3):209-13. PubMed ID: 88280 [Abstract] [Full Text] [Related]
2. Randomized comparison of ABVD and MOPP/ABV hybrid for the treatment of advanced Hodgkin's disease: report of an intergroup trial. Duggan DB, Petroni GR, Johnson JL, Glick JH, Fisher RI, Connors JM, Canellos GP, Peterson BA. J Clin Oncol; 2003 Feb 15; 21(4):607-14. PubMed ID: 12586796 [Abstract] [Full Text] [Related]
3. Salvage chemotherapy with ABVD in MOPP-resistant Hodgkin's disease. Santoro A, Bonfante V, Bonadonna G. Ann Intern Med; 1982 Feb 15; 96(2):139-43. PubMed ID: 6174060 [Abstract] [Full Text] [Related]
8. Treatment of advanced Hodgkin's disease with chemotherapy--comparison of MOPP/ABV hybrid regimen with alternating courses of MOPP and ABVD: a report from the National Cancer Institute of Canada clinical trials group. Connors JM, Klimo P, Adams G, Burns BF, Cooper I, Meyer RM, O'Reilly SE, Pater J, Quirt I, Sadura A, Shustik C, Skillings J, Sutcliffe S, Verma S, Yoshida S, Zee B. J Clin Oncol; 1997 Apr 15; 15(4):1638-45. PubMed ID: 9193364 [Abstract] [Full Text] [Related]
9. Prolonged disease-free survival in MOPP-resistant Hodgkin's disease after treatment with adriamycin, bleomycin, vinblastine and dacarbazine (ABVD). Santoro A, Bonadonna G. Cancer Chemother Pharmacol; 1979 Apr 15; 2(2):101-5. PubMed ID: 93984 [Abstract] [Full Text] [Related]
16. Spermatogenesis in Hodgkin's lymphoma patients: a retrospective study of semen quality before and after different chemotherapy regimens. Paoli D, Rizzo F, Fiore G, Pallotti F, Pulsoni A, Annechini G, Lombardo F, Lenzi A, Gandini L. Hum Reprod; 2016 Feb 15; 31(2):263-72. PubMed ID: 26705149 [Abstract] [Full Text] [Related]
18. Cyclic delivery of MOPP and ABVD combinations in Stage IV Hodgkin's disease: rationale, background studies, and recent results. Bonadonna G, Santoro A, Bonfante V, Valagussa P. Cancer Treat Rep; 1982 Apr 15; 66(4):881-7. PubMed ID: 6176323 [Abstract] [Full Text] [Related]
19. Treatment of MOPP-resistant Hodgkin's disease with adriamycin, bleomycin, vinblastine and dacarbazine (ABVD). Papa G, Mandelli F, Anselmo AP, De Luca AM, Maurizienrici R, Mauro F, Testi AM, Amadori S, Biagini C. Eur J Cancer Clin Oncol; 1982 Sep 15; 18(9):803-6. PubMed ID: 6185342 [No Abstract] [Full Text] [Related]
20. Randomized study of intensive MOPP-ABVD with or without low-dose total-nodal radiation therapy in the treatment of stages IIB, IIIA2, IIIB, and IV Hodgkin's disease in pediatric patients: a Pediatric Oncology Group study. Weiner MA, Leventhal B, Brecher ML, Marcus RB, Cantor A, Gieser PW, Ternberg JL, Behm FG, Wharam MD, Chauvenet AR. J Clin Oncol; 1997 Aug 15; 15(8):2769-79. PubMed ID: 9256118 [Abstract] [Full Text] [Related] Page: [Next] [New Search]